Search research articles
Contact Us
Filters
Showing results (51-60 of 174) with videos related to
Page
of 18
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)
|
April 21, 2015
Efficacy and safety of etanercept in patients with the enthesitis-related arthritis category of juvenile idiopathic arthritis: results from a phase III randomized, double-blind study
Gerd Horneff, Ivan Foeldvari, Kirsten Minden, et al.
The Lancet. Child & Adolescent Health
|
April 28, 2023
Off-label is not always off-evidence: authorising paediatric indications for old medicines
Saskia N de Wildt, Ivan Foeldvari, Angeliki Siapkara, et al.
Rheumatology (Oxford, England)
|
December 3, 2015
Efficacy and safety of biological agents for systemic juvenile idiopathic arthritis: a systematic review and meta-analysis of randomized trials
Simon Tarp, Gil Amarilyo, Ivan Foeldvari, et al.
Seminars in Arthritis and Rheumatism
|
December 20, 2016
Biological agents in polyarticular juvenile idiopathic arthritis: A meta-analysis of randomized withdrawal trials
Gil Amarilyo, Simon Tarp, Ivan Foeldvari, et al.
The Journal of Rheumatology
|
March 9, 2007
Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey
Ivan Foeldvari, Susanne Nielsen, Jasmin Kümmerle-Deschner, et al.
Rheumatology (Oxford, England)
|
June 26, 2012
Juvenile and young adult-onset systemic sclerosis share the same organ involvement in adulthood: data from the EUSTAR database
Ivan Foeldvari, Alan Tyndall, Francesco Zulian, et al.
Rheumatology International
|
September 13, 2017
An international SUrvey on non-iNvaSive tecHniques to assess the mIcrocirculation in patients with RayNaud's phEnomenon (SUNSHINE survey)
Francesca Ingegnoli, Nicola Ughi, Graham Dinsdale, et al.
Arthritis Research & Therapy
|
November 24, 2017
Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry
Gerd Horneff, Anna Carina Schulz, Jens Klotsche, et al.
Rheumatology (Oxford, England)
|
June 2, 2009
Safety and efficacy of once weekly etanercept 0.8 mg/kg in a multicentre 12 week trial in active polyarticular course juvenile idiopathic arthritis
Gerd Horneff, Annette Ebert, Sigrid Fitter, et al.
The Journal of Pediatrics
|
December 17, 2017
Comorbidity of Type 1 Diabetes Mellitus in Patients with Juvenile Idiopathic Arthritis
Sandra Schenck, Joachim Rosenbauer, Martina Niewerth, et al.
Page
of 18
Search research articles
Search
Showing results (51-60 of 174) with videos related to
Sort By:
Page
of 18
Arthritis & Rheumatology (Hoboken, N.J.)
|
April 21, 2015
Efficacy and safety of etanercept in patients with the enthesitis-related arthritis category of juvenile idiopathic arthritis: results from a phase III randomized, double-blind study
Gerd Horneff, Ivan Foeldvari, Kirsten Minden, et al.
The Lancet. Child & Adolescent Health
|
April 28, 2023
Off-label is not always off-evidence: authorising paediatric indications for old medicines
Saskia N de Wildt, Ivan Foeldvari, Angeliki Siapkara, et al.
Rheumatology (Oxford, England)
|
December 3, 2015
Efficacy and safety of biological agents for systemic juvenile idiopathic arthritis: a systematic review and meta-analysis of randomized trials
Simon Tarp, Gil Amarilyo, Ivan Foeldvari, et al.
Seminars in Arthritis and Rheumatism
|
December 20, 2016
Biological agents in polyarticular juvenile idiopathic arthritis: A meta-analysis of randomized withdrawal trials
Gil Amarilyo, Simon Tarp, Ivan Foeldvari, et al.
The Journal of Rheumatology
|
March 9, 2007
Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey
Ivan Foeldvari, Susanne Nielsen, Jasmin Kümmerle-Deschner, et al.
Rheumatology (Oxford, England)
|
June 26, 2012
Juvenile and young adult-onset systemic sclerosis share the same organ involvement in adulthood: data from the EUSTAR database
Ivan Foeldvari, Alan Tyndall, Francesco Zulian, et al.
Rheumatology International
|
September 13, 2017
An international SUrvey on non-iNvaSive tecHniques to assess the mIcrocirculation in patients with RayNaud's phEnomenon (SUNSHINE survey)
Francesca Ingegnoli, Nicola Ughi, Graham Dinsdale, et al.
Arthritis Research & Therapy
|
November 24, 2017
Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry
Gerd Horneff, Anna Carina Schulz, Jens Klotsche, et al.
Rheumatology (Oxford, England)
|
June 2, 2009
Safety and efficacy of once weekly etanercept 0.8 mg/kg in a multicentre 12 week trial in active polyarticular course juvenile idiopathic arthritis
Gerd Horneff, Annette Ebert, Sigrid Fitter, et al.
The Journal of Pediatrics
|
December 17, 2017
Comorbidity of Type 1 Diabetes Mellitus in Patients with Juvenile Idiopathic Arthritis
Sandra Schenck, Joachim Rosenbauer, Martina Niewerth, et al.
Page
of 18